INTERNATIONAL PATENT: CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD., 长春金赛药业有限责任公司 FILES APPLICATION FOR "ANTIBODY, BISPECIFIC ANTIBODY AND CONJUGATE TARGETING FOLATE RECEPTOR Α (FRΑ) AND PREPARATION AND USE THEREOF"

GENEVA, Dec. 15 -- CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. (1718 Yueda Road, Changchun High-Tech Dev. ZoneChangchun, Jilin 130012), 长春金赛药业有限责任公司 (中国吉林省长春市高新区越达路1718号) filed a patent application (PCT/CN2025/098911) for "ANTIBODY, BISPECIFIC ANTIBODY AND CONJUGATE TARGETING FOLATE RECEPTOR Alpha (FRAlpha), AND PREPARATION AND USE THEREOF" on Jun 04, 2025. With publication no. WO/2025/252094, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classi...